An SHP-2 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

GDC-1971

Item No. 39884

Technical Information
Formal Name
(3R)-1′-[3-(3,4-dihydro-1,5-naphthyridin-1(2H)-yl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-spiro[benzofuran-2(3H),4′-piperidin]-3-amine
CAS Number
2377352-49-1
Synonyms
  • Migoprotafib
Molecular Formula
C25H26N8O
Formula Weight
Purity
≥98%
Formulation
A solid
Acetonitrile: Slightly soluble: 0.1-1 mg/mlMethanol: Sparingly soluble: 1-10 mg/ml
SMILES
N[C@@H]1C2=CC=CC=C2OC31CCN(CC3)C4=CN=C5C(N6C7=CC=CN=C7CCC6)=NNC5=N4
InChi Code
InChI=1S/C25H26N8O/c26-22-16-5-1-2-8-19(16)34-25(22)9-13-32(14-10-25)20-15-28-21-23(29-20)30-31-24(21)33-12-4-6-17-18(33)7-3-11-27-17/h1-3,5,7-8,11,15,22H,4,6,9-10,12-14,26H2,(H,29,30,31)/t22-/m1/s1
InChi Key
RGCGBFIARQENML-JOCHJYFZSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    GDC-1971 is an inhibitor of Src homology region 2 domain-containing phosphatase 2 (SHP-2; IC50 = <0.001 µM).1 It is selective for SHP-2 over SHP-2 containing a glutamate-to-lysine substitution at position 76 (SHP-2E76K; IC50 = 0.17 µM). GDC-1971 reduces the levels of phosphorylated ERK in a reporter assay using KYSE-520 esophageal cancer cells (IC90 = 0.012 µM) and inhibits proliferation of the same cells (IC50 = 0.32 µM). In vivo, GDC-1971 (30 or 100 mg/kg two times per day) reduces tumor volume in KYSE-520 and NCI H358 non-small cell lung cancer (NSCLC) mouse xenograft models.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Taylor, A.M., Williams, B.R., Giordanetto, F., et alIdentification of GDC-1971 (RLY-1971), a SHP2 inhibitor designed for the treatment of solid tumors. J. Med. Chem. 66(19), 13384-13399 (2023).